Table 5.

Prevalence of erectile dysfunction (ED)^* by hyperlipidemia^†, age and comorbidity status among men contributing blood samples in Boston Area Community Health Survey, 2002–2005, N=1899.

		Prevalence of ED (%‡)
Subgroup	Total N	Overall	Treated hyperlipidemia	Untreated hyperlipidemia	No hyperlipidemia
Age <55	1291	14.1%	39.5%	3.9%	13.5%
N with ED		234	41	21	172
Age 55+	608	38.1%	47.4%	29.7%	34.0%
N with ED		257	91	25	141
Age <55 and CVD§ and/or diabetes	239	23.1%	60.7%	3.8%	13.0%
N with ED		66	29	4	34
Age <55, no CVD or diabetes	1052	12.1%	13.7%	3.9%	13.6%
N with ED		168	12	17	139
Age 55+ and CVD and/or diabetes	267	51.4%	52.8%	50.4%	49.9%
N with ED		143	65	10	68
Age 55+, no CVD or diabetes	341	27.5%	36.5%	22.5%	25.7%
N with ED		114	25	15	73

^*Erectile dysfunction was defined as an IIEF-5 score of ≤16.

^†Treated hyperlipidemia was defined as taking prescription anti-lipid medication, untreated hyperlipidemia was measured serum total cholesterol of ≥240 mg/dL without taking prescription anti-lipid medication, and no hyperlipidemia was defined as no use of anti-lipid medications and total serum cholesterol <240.

^‡Prevalence percentages were weighted by the inverse of the probability of being sampled.

^§Any history of coronary artery bypass surgery or angioplasty, heart attack, angina, having a pacemaker, congestive heart failure, transient ischemic attack, stroke, carotid artery surgery, intermittent claudication, surgery or angioplasty for arterial disease of the leg, pulmonary embolism, aortic aneurysm, heart-rhythm disturbance, deep vein thrombosis, Reynaud's disease or peripheral vascular disease.